This is thought to be due to the CDKN2A and CDKN2B genes in this genomic region inhibiting CDK4 and CDK6, which has been demonstrated to influence β cell proliferation and mass, eventually leading to diabetes [34–36]. This evidence concerns the gene CDKN2A and diabetes mellitus.